Blog With Breast Cancer, It’s Personal Oct 14, 2013 40 years of advances have taken us from a time when disfiguring surgery was the only real treatment option to an era where we can tailor targeted therapies for individual subgroups and patients. While it may not be possible to get rid of someone’s cancer, innovative therapies are enabling doctors to manage breast cancer more effectively. Our Long War on Cancer Oct 07, 2013 As we kick off a month filled with reminders about the most common cause of cancer in women—and a Eureka series devoted to cancer—one could and should ask why it’s been so difficult to translate the findings from research into new tools and drugs in the clinic; and what the field needs to do differently to get the job done. The Geometry of Mice in Motion Sep 30, 2013 Challenges—and progress—in diagnosing and translating CNS disease from mouse to men Ouch! The Problem with Those Pain Models Sep 23, 2013 To the dismay of millions of chronic pain sufferers, the search for novel analgesics over the past several decades hasn’t produced much relief. In fact, it’s been one big pain in the…well, you know. Making Efficacy Models Count Sep 16, 2013 Animal models of disease have contributed widely to the development of new drugs for the treatment of many human diseases such as cancer, diabetes or infectious diseases The Silent Killer Sep 10, 2013 Hypertension, or high blood pressure, is a stealth-like condition that can wield a large and very dangerous stick. An Old Idea is Becoming the Future of Melanoma Therapy Sep 03, 2013 To truly appreciate what immunotherapy means for the treatment of melanoma (and eventually other cancers) it is useful to take a step back and look at the rationale and history of efforts in the field. An Alternative Source of Pluripotent Stem Cells Aug 26, 2013 The earliest uses of stem cells in regenerative medicine occurred in the 1960s with the advent of bone-marrow derived stem cell transplants. Since that time, stem cell research has advanced to the forefront of science. The Human Microbiome Aug 16, 2013 Symbionts, pathogens and free-loaders! Are Your Cells Having an Identity Crisis? Aug 13, 2013 There are several regulatory guidelines related to full characterization of recombinant cell banks used to generate biological drug products. Ultimately, however, the task of the cell bank researcher often comes down to answering one question: Is my organism what I think it is? Displaying results 1-10 (of 91) |< < 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 > >|
With Breast Cancer, It’s Personal Oct 14, 2013 40 years of advances have taken us from a time when disfiguring surgery was the only real treatment option to an era where we can tailor targeted therapies for individual subgroups and patients. While it may not be possible to get rid of someone’s cancer, innovative therapies are enabling doctors to manage breast cancer more effectively.
Our Long War on Cancer Oct 07, 2013 As we kick off a month filled with reminders about the most common cause of cancer in women—and a Eureka series devoted to cancer—one could and should ask why it’s been so difficult to translate the findings from research into new tools and drugs in the clinic; and what the field needs to do differently to get the job done.
The Geometry of Mice in Motion Sep 30, 2013 Challenges—and progress—in diagnosing and translating CNS disease from mouse to men
Ouch! The Problem with Those Pain Models Sep 23, 2013 To the dismay of millions of chronic pain sufferers, the search for novel analgesics over the past several decades hasn’t produced much relief. In fact, it’s been one big pain in the…well, you know.
Making Efficacy Models Count Sep 16, 2013 Animal models of disease have contributed widely to the development of new drugs for the treatment of many human diseases such as cancer, diabetes or infectious diseases
The Silent Killer Sep 10, 2013 Hypertension, or high blood pressure, is a stealth-like condition that can wield a large and very dangerous stick.
An Old Idea is Becoming the Future of Melanoma Therapy Sep 03, 2013 To truly appreciate what immunotherapy means for the treatment of melanoma (and eventually other cancers) it is useful to take a step back and look at the rationale and history of efforts in the field.
An Alternative Source of Pluripotent Stem Cells Aug 26, 2013 The earliest uses of stem cells in regenerative medicine occurred in the 1960s with the advent of bone-marrow derived stem cell transplants. Since that time, stem cell research has advanced to the forefront of science.
Are Your Cells Having an Identity Crisis? Aug 13, 2013 There are several regulatory guidelines related to full characterization of recombinant cell banks used to generate biological drug products. Ultimately, however, the task of the cell bank researcher often comes down to answering one question: Is my organism what I think it is?
